Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission

Krishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle · 2024

Read Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission by Krishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11610725.txt.

Description

IntroductionAs fentanyl has become more readily available, opioid-related morbidity and mortality in the United States has increased dramatically. Preliminary studies suggest that high-affinity, partial mu-opioid receptor agonists such as the combination product buprenorphine-naloxone may reduce mortality from overdose and promote remission.

Catalog record

CREATORKrishna K Paul, Christian G Frey, Stanley Troung, Laura vita Q Paglicawan, Kathryn A Cunningham, T Preston Hill, Lauren G Bothwell, Georgiy Golovko, Yeoshina Pillay, Dietrich Jehle
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11610725

Browse the full library · About the Tower of Babel